Searched for: person:barrej24
in-biosketch:true
Orthoplastic Surgery: A Practical Approach to Limb Salvage
Barrera, Janos; Levine, Jamie; Levin, L Scott; Hacquebord, Jacques
Complex extremity wounds, if not addressed properly, are a leading cause of major limb amputation. Chronic wounds in salvaged extremities contribute to long-term morbidity in the extremity. Orthoplastic surgery treats limb-threatening conditions through the combined application of orthopaedic and plastic surgical principles, applied to clinical problems simultaneously. Key components include early stakeholder evaluation of the limb and patient and open collaborative communication between orthopaedic and plastic surgeons. Meticulous débridement at the time of presentation and careful selection of fixation informed by the overall reconstructive plan should be executed when the patient presents to the emergency department. Implementation of Orthoplastic protocols results in quicker time to skeletal stabilization and soft tissue coverage, reduced risk of infection, improved functional outcomes, and less cost for care. This review presents a protocol-driven guide for establishing an Orthoplastic program and optimizing limb salvage outcomes across diverse practice settings.
PMID: 42335408
ISSN: 1940-5480
CID: 6055602
Current diagnostic methods for detecting avascular necrosis and irreversible bone death of the proximal pole of the scaphoid: a systematic review
Jacobi, Sophia; Davidovic-Katz, Emily; Moll, Samara; Barrera, Janos; Shah, Ajul; Hacquebord, Jacques H
INTRODUCTION/BACKGROUND:Owing to the scaphoid's retrograde blood supply, fractures can compromise perfusion to the proximal pole, making it vulnerable to avascular necrosis (AVN) or irreversible bone death. Despite their differing prognoses, both conditions are evaluated using the same diagnostic methods. This review aims to determine the most reliable method of distinguishing between AVN and irreversible bone death, considering factors such as magnetic resonance imaging (MRI), computed tomography (CT), intraoperative findings, and histology. METHODS:A comprehensive literature search was conducted until November 2024. The diagnostic methods and criteria for AVN were collected, and the outcome was measured dichotomously as either resolution of AVN or irreversible bone death. Each AVN diagnostic method was categorized and the healing outcomes of all patients diagnosed with AVN in the study were compared. RESULTS:This systematic review included 27 studies and 423 patients. With regard to AVN healing, 195 out of 223 patients diagnosed with AVN via MRI eventually healed. Of those diagnosed with AVN via CT, nine out of 21 went on to heal, as did 308 out of 356 patients with no intraoperative punctate bleeding. Histologic evaluation had the lowest incidence of AVN resolution, with only six out of 19 patients healing. CONCLUSION/CONCLUSIONS:All diagnostic methods identified AVN resolution and irreversible bone death. However, all patients were solely diagnosed with AVN. There is no standardized method for diagnosing irreversible bone death because the existing literature conflates irreversible bone death with AVN, despite their distinct pathologies and prognoses. Consequently, our understanding of AVN and the point at which irreversible bone death occurs in the scaphoid is limited.
PMID: 42170849
ISSN: 2043-6289
CID: 6038732
A case report of primary synovial chondromatosis of the elbow
Tong, Yixuan; Barrera, Janos; Tedesco, Liana; Ayalon, Omri B
This case is a 37-year-old man with diffuse primary synovial chondromatosis of the elbow, with associated ulnar nerve compression and flexion contracture at the elbow. An open synovectomy with removal of loose bodies and an ulnar nerve decompression with anterior subcutaneous transposition were performed. Postoperatively, the patient's elbow mobility and nerve compression symptoms improved steadily, which significantly improved his function. Primary synovial chondromatosis of the elbow is a rare disease that can result in pain, swelling, decreased range of motion, and mechanical symptoms. Treatment usually involves synovectomy and removal of loose bodies to address patients' pain and joint motion.
PMCID:12975010
PMID: 41784542
ISSN: 2328-5273
CID: 6009022
Patient-Related Factors Associated With Scaphoid Proximal Pole Avascular Necrosis Healing
Jacobi, Sophia; Davidovic-Katz, Emily; Richardson, Michelle; Moll, Samara; Barrera, Janos; Hacquebord, Jacques
BACKGROUND:Avascular necrosis (AVN) of the proximal pole is a well-known complication of scaphoid fractures. Avascular necrosis is poorly understood, including the transition from ischemia to necrosis, optimal treatment, and why some AVN heals but others do not. The primary purpose of this study is to evaluate patient-related factors that are associated with healing outcomes in individuals with proximal pole AVN following scaphoid fractures. METHODS:This is a retrospective review of all patients diagnosed with scaphoid proximal pole AVN secondary to a fracture from 2018 to 2024 in a single center. Patient baseline characteristics and comorbidities at time of diagnosis were collected. If the patient underwent surgical management, procedural factors were collected. The primary outcome was AVN healing after 4 months of follow-up. RESULTS:= .886, respectively). CONCLUSIONS:Hyperlipidemia, elevated BMI, and advanced age are patient factors negatively associated with scaphoid proximal pole AVN healing-key information for accurately assessing patient prognosis. For surgical management, the choice of a vascularized bone, nonvascularized bone graft, or no graft does not significantly impact AVN healing.
PMCID:12834686
PMID: 41582392
ISSN: 1558-9455
CID: 6002912
Complications and Outcomes of Bone-Anchored Prostheses of the Hand: A Systematic Review
Bates, Taylor; Tedesco, Liana J; Barrera, Janos; Margalit, Adam; Fitzgerald, Michael; Hacquebord, Jacques; Ayalon, Omri
PURPOSE/OBJECTIVE:The purpose of this study was to conduct a systematic review evaluating the reported complications and outcomes of bone-anchored prostheses in digit and partial hand amputees. METHODS:A literature review of primary research articles on osseointegration and bone-anchored prostheses for digit and partial amputees was performed. The Medline, Embase, Scopus, and Cochrane Library databases were queried. Inclusion criteria were journal articles that evaluated osseointegration and bone-anchored prostheses in digit and partial hand amputees. The main outcome measures were reported complications and the need for revision surgery. Secondary outcomes included all reported outcome assessments. RESULTS:Fifteen articles were included with publication dates ranging from 1996 to 2022. The sample sizes ranged from single-patient case reports to a 13-patient retrospective study. Overall, 33 men and 16 women were reported with a mean age of 33.6 years (range: 12-68) and a total of 71 amputated digits. The median follow-up was 2.1 years (IQR: 1.1-6.8 years). A total of 24 complications were reported in 14 digits (19.7%). Complications included superficial infection in 6 digits (8.5%), abutment loosening or failure in 5 (7%), fixture aseptic loosening in 4 (5.6%), deep infection in 1 (1.4%), and soft tissue instability in 1 (1.4%). Sixteen revision surgeries or component changes were reported. CONCLUSIONS:Bone-anchored prostheses using osseointegrated implants in the hand are associated with favorable outcomes in the limited number of low-quality studies available for review. Superficial infections and implant-related failures were the most frequently reported complications. TYPE OF STUDY/LEVEL OF EVIDENCE/METHODS:Systematic review IV.
PMID: 39570221
ISSN: 1531-6564
CID: 5758752
Allometrically scaling tissue forces drive pathological foreign-body responses to implants via Rac2-activated myeloid cells
Padmanabhan, Jagannath; Chen, Kellen; Sivaraj, Dharshan; Henn, Dominic; Kuehlmann, Britta A; Kussie, Hudson C; Zhao, Eric T; Kahn, Anum; Bonham, Clark A; Dohi, Teruyuki; Beck, Thomas C; Trotsyuk, Artem A; Stern-Buchbinder, Zachary A; Than, Peter A; Hosseini, Hadi S; Barrera, Janos A; Magbual, Noah J; Leeolou, Melissa C; Fischer, Katharina S; Tigchelaar, Seth S; Lin, John Q; Perrault, David P; Borrelli, Mimi R; Kwon, Sun Hyung; Maan, Zeshaan N; Dunn, James C Y; Nazerali, Rahim; Januszyk, Michael; Prantl, Lukas; Gurtner, Geoffrey C
Small animals do not replicate the severity of the human foreign-body response (FBR) to implants. Here we show that the FBR can be driven by forces generated at the implant surface that, owing to allometric scaling, increase exponentially with body size. We found that the human FBR is mediated by immune-cell-specific RAC2 mechanotransduction signalling, independently of the chemistry and mechanical properties of the implant, and that a pathological FBR that is human-like at the molecular, cellular and tissue levels can be induced in mice via the application of human-tissue-scale forces through a vibrating silicone implant. FBRs to such elevated extrinsic forces in the mice were also mediated by the activation of Rac2 signalling in a subpopulation of mechanoresponsive myeloid cells, which could be substantially reduced via the pharmacological or genetic inhibition of Rac2. Our findings provide an explanation for the stark differences in FBRs observed in small animals and humans, and have implications for the design and safety of implantable devices.
PMCID:10651488
PMID: 37749310
ISSN: 2157-846x
CID: 5678232
Blockchain, Information Security, Control, and Integrity: Who Is in Charge?
Barrera, Janos A; Trotsyuk, Artem A; Henn, Dominic; Sivaraj, Dharshan; Chen, Kellen; Mittal, Smiti; Mermin-Bunnell, Alana M; Larson, Madelyn R; Padmanabhan, Jagannath; Kinney, Brian; Nachbar, James; Sacks, Justin; Terkonda, Sarvam P; Jeffers, Lynn; Gurtner, Geoffrey C
Blockchain technology has attracted substantial interest in recent years, most notably for its effect on global economics through the advent of cryptocurrency. Within the health care domain, blockchain technology has been actively explored as a tool for improving personal health data management, medical device security, and clinical trial management. Despite a strong demand for innovation and cutting-edge technology in plastic surgery, integration of blockchain technologies within plastic surgery is in its infancy. Recent advances and mainstream adoption of blockchain are gaining momentum and have shown significant promise for improving patient care and information management. In this article, the authors explain what defines a blockchain and discuss its history and potential applications in plastic surgery. Existing evidence suggests that blockchain can enable patient-centered data management, improve privacy, and provide additional safeguards against human error. Integration of blockchain technology into clinical practice requires further research and development to demonstrate its safety and efficacy for patients and providers.
PMID: 36917745
ISSN: 1529-4242
CID: 5678452
Cas9-mediated knockout of Ndrg2 enhances the regenerative potential of dendritic cells for wound healing
Henn, Dominic; Zhao, Dehua; Sivaraj, Dharshan; Trotsyuk, Artem; Bonham, Clark Andrew; Fischer, Katharina S; Kehl, Tim; Fehlmann, Tobias; Greco, Autumn H; Kussie, Hudson C; Moortgat Illouz, Sylvia E; Padmanabhan, Jagannath; Barrera, Janos A; Kneser, Ulrich; Lenhof, Hans-Peter; Januszyk, Michael; Levi, Benjamin; Keller, Andreas; Longaker, Michael T; Chen, Kellen; Qi, Lei S; Gurtner, Geoffrey C
Chronic wounds impose a significant healthcare burden to a broad patient population. Cell-based therapies, while having shown benefits for the treatment of chronic wounds, have not yet achieved widespread adoption into clinical practice. We developed a CRISPR/Cas9 approach to precisely edit murine dendritic cells to enhance their therapeutic potential for healing chronic wounds. Using single-cell RNA sequencing of tolerogenic dendritic cells, we identified N-myc downregulated gene 2 (Ndrg2), which marks a specific population of dendritic cell progenitors, as a promising target for CRISPR knockout. Ndrg2-knockout alters the transcriptomic profile of dendritic cells and preserves an immature cell state with a strong pro-angiogenic and regenerative capacity. We then incorporated our CRISPR-based cell engineering within a therapeutic hydrogel for in vivo cell delivery and developed an effective translational approach for dendritic cell-based immunotherapy that accelerated healing of full-thickness wounds in both non-diabetic and diabetic mouse models. These findings could open the door to future clinical trials using safe gene editing in dendritic cells for treating various types of chronic wounds.
PMCID:10406832
PMID: 37550295
ISSN: 2041-1723
CID: 5678222
Robotics in Plastic Surgery: It's Here
Henn, Dominic; Trotsyuk, Artem A; Barrera, Janos A; Sivaraj, Dharshan; Chen, Kellen; Mittal, Smiti; Mermin-Bunnell, Alana M; Chattopadhyay, Arhana; Larson, Madelyn R; Kinney, Brian M; Nachbar, James; TerKonda, Sarvam P; Reddy, Sashank; Jeffers, Lynn; Sacks, Justin M; Gurtner, Geoffrey C
Although robotic surgery has been routinely established in other surgical disciplines, robotic technologies have been less readily adopted in plastic surgery. Despite a strong demand for innovation and cutting-edge technology in plastic surgery, most reconstructive procedures, including microsurgery, have continued to necessitate an open approach. Recent advances in robotics and artificial intelligence, however, are gaining momentum and have shown significant promise to improve patient care in plastic surgery. These next-generation surgical robots have the potential to enable surgeons to perform complex procedures with greater precision, flexibility, and control than previously possible with conventional techniques. Successful integration of robotic technologies into clinical practice in plastic surgery requires achieving key milestones, including implementing appropriate surgical education and garnering patient trust.
PMID: 37382921
ISSN: 1529-4242
CID: 5678442
Postoperative Antibiotics Confer No Protective Association After Fat Grafting for Breast Reconstruction
Thawanyarat, Kometh; Johnstone, Thomas; Rowley, Mallory; Kim, Trudy; Francis, Shannon; Barrera, Janos; Cheeseborough, Jennifer; Sheckter, Clifford; Nazerali, Rahim
INTRODUCTION:Autologous fat grafting after breast reconstruction is a commonly used technique to address asymmetry and irregularities in breast contour. While many studies have attempted to optimize patient outcomes after fat grafting, a key postoperative protocol that lacks consensus is the optimal use of perioperative and postoperative antibiotics. Reports suggest that complication rates for fat grafting are low relative to rates after reconstruction and have been shown to not be correlated to antibiotic protocol. Studies have additionally demonstrated that the use of prolonged prophylactic antibiotics do not lower the complication rates, stressing the need for a more conservative, standardized antibiotic protocol. This study aims to identify the optimal use of perioperative and postoperative antibiotics that optimizes patient outcomes. METHODS:Patients in the Optum Clinformatics Data Mart who underwent all billable forms of breast reconstruction followed by fat grafting were identified via Current Procedural Terminology codes. Patients meeting inclusion criteria had an index reconstructive procedure at least 90 days before fat grafting. Data concerning these patient's demographics, comorbidities, breast reconstructions, perioperative and postoperative antibiotics, and outcomes were collected via querying relevant reports of Current Procedural Terminology ; International Classification of Diseases, Ninth Revision ; International Classification of Diseases, Tenth Revision ; National Drug Code Directory, and Healthcare Common Procedure Coding System codes. Antibiotics were classified by type and temporal delivery: perioperatively or postoperatively. If a patient received postoperative antibiotics, the duration of antibiotic exposure was recorded. Outcomes analysis was limited to the 90-day postoperative period. Multivariable logistic regression was performed to ascertain the effects of age, coexisting conditions, reconstruction type (autologous or implant-based), perioperative antibiotic class, postoperative antibiotic class, and postoperative antibiotic duration on the likelihood of any common postoperative complication occurring. All statistical assumptions made by logistic regression were met successfully. Odds ratios and corresponding 95% confidence intervals were calculated. RESULTS:From more than 86 million longitudinal patient records between March 2004 and June 2019, our study population included 7456 unique records of reconstruction-fat grafting pairs, with 4661 of those pairs receiving some form of prophylactic antibiotics. Age, prior radiation, and perioperative antibiotic administration were consistent independent predictors of increased all-cause complication likelihood. However, administration of perioperative antibiotics approached a statistically significant protective association against infection likelihood. No postoperative antibiotics of any duration or class conferred a protective association against infections or all-cause complications. CONCLUSIONS:This study provides national, claims-level support for antibiotic stewardship during and after fat grafting procedures. Postoperative antibiotics did not confer a protective benefit association against infection or all-cause complication likelihood, while administering perioperative antibiotics conferred a statistically significant increase in the likelihood that a patient experienced postoperative complication. However, perioperative antibiotics approach a significant protective association against postoperative infection likelihood, in line with current guidelines for infection prevention. These findings may encourage the adoption of more conservative postoperative prescription practices for clinicians who perform breast reconstruction, followed by fat grafting, reducing the nonindicated use of antibiotics.
PMID: 36880783
ISSN: 1536-3708
CID: 5678212